MS

Abbott, Biogen Idec say multiple sclerosis drug achieved study goal of decreasing relapse
Yahoo/AP
Mon, 10/24/11 - 11:00 am
Abbott Laboratories
Biogen Idec
MS
multiple sclerosis
daclizumab
Biogen, Questcor, Allergan Up On MS News
Investors.com
Fri, 10/21/11 - 12:50 pm
Biogen Idec
Questcor
Allergan
MS
multiple sclerosis
BG-12
Biogen says potential MS drug outperforms placebo
Yahoo/AP
Fri, 10/21/11 - 10:09 am
MS
Biogen Idec
multiple sclerosis
BG-12
Biogen Idec, Elan Say FDA Extends Date to Decide Tysabri Change
Bloomberg
Thu, 10/20/11 - 09:17 am
Biogen Idec
FDA
Elan
Tysabri
MS
multiple sclerosis
Teva's Copaxone reduced brain volume loss in patients, according to study
Drugstore News
Wed, 10/12/11 - 10:51 am
Copaxone
Teva Pharmaceuticals
MS
multiple sclerosis
Sanofi Earns a "Modest" Win With Positive Oral MS PhIII Data
Motley Fool
Thu, 10/6/11 - 12:01 pm
Sanofi
MS
multiple sclerosis
teriflunomide
Biogen MS trial data reveals no safety surprises
Reuters
Wed, 10/5/11 - 10:49 am
Biogen Idec
multiple sclerosis
MS
BG-12
Antares Scores Key Patent Possibly Linked To TEVA's Copaxone
Seeking Alpha
Fri, 09/30/11 - 10:55 am
Antares
patents
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
Questcor Pharmaceuticals sees Acthar Gel MS prescriptions poised for 3rd-quarter growth
Yahoo/AP
Wed, 09/28/11 - 12:32 pm
Questcor
Acthar
multiple sclerosis
MS
Questcor falls on slower new Acthar prescriptions
Yahoo/AP
Mon, 09/12/11 - 01:26 pm
Questcor
Acthar
MS
multiple sclerosis
Teva defense of Copaxone starts today
Pharma Times, UK
Wed, 09/7/11 - 11:20 am
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
patents
Teva Gains to 4-Week High After U.S. Court Denies Motion
Bloomberg
Tue, 08/30/11 - 11:33 am
Teva Pharmaceuticals
patents
Copaxone
Mylan
MS
multiple sclerosis
Teva wins ruling in Copaxone patent lawsuit
Globes, Israel
Mon, 08/29/11 - 01:14 pm
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
Analyst upgrades drugmaker Elan on higher expectations for multiple sclerosis drug Tysabri
Yahoo/AP
Thu, 08/25/11 - 08:24 am
Elan
Biogen Idec
MS
Tysabri
multiple sclerosis
Biogen and Abbott advance MS drug candidate
Bizjournals.com
Tue, 08/9/11 - 01:13 pm
DAC HYP
multiple sclerosis
MS
Abbott Laboratories
Biogen Idec
dalcizumab HYP
Teva study gives Biogen a lift
Yahoo/InvestorsBusinessDaily
Tue, 08/2/11 - 11:33 am
Teva Pharmaceuticals
Biogen Idec
MS
multiple sclerosis
laquinimod
Active Biotech shares slump after Phase III result
Marketwatch
Mon, 08/1/11 - 10:22 am
Active Biotech
laquinimod
Teva Pharmaceuticals
MS
multiple sclerosis
Biogen wins conditional EU approval for MS drug
Bizjournals.com
Mon, 07/25/11 - 10:25 am
Biogen Idec
Europe
MS
multiple sclerosis
Fampyra
Biogen, Bayer MS Drugs Aren’t Cost Effective, Study Says
Bloomberg
Thu, 07/21/11 - 12:19 pm
MS
multiple sclerosis
Biogen Idec
Bayer
Avonex
Betaseron
5 Biotech Drug-Launch Stocks to Watch
TheStreet.com
Mon, 07/18/11 - 10:03 am
Human Genome Sciences
Vertex Pharmaceuticals
Acorda Therapeutics
Dendreon
Avanir
lupus
Benlysta
Incivek
hepatitis C
MS
AMPYRA
Provenge
prostate cancer
Nuedexta
PBA

Pages